Medicament preparations for transdermal application...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/70 (2006.01) A61K 31/13 (2006.01) A61K 31/381 (2006.01) A61K 31/428 (2006.01) A61K 45/06 (2006.01) A61P 25/16 (2006.01)

Patent

CA 2535063

The invention relates to medicament preparations for transdermal application used in the treatment of Parkinson's disease. Said preparations contain a combination of at least two active ingredients, selected from the following groups of active ingredients: dopamine agonists and L-dopa, monoaminoxidase inhibitors, anticholinergics, NMDA receptor antagonists and sympathomimetics, whereby at least two of the active ingredients belong to different active ingredient groups.

La présente invention concerne des préparations pharmaceutiques pour administration transdermique, utilisées pour traiter la maladie de Parkinson, contenant une combinaison d'au moins deux principes actifs qui sont sélectionnés dans les groupes de principes actifs suivants: agonistes de la dopamine et L-Dopa, inhibiteurs de la monoaminoxidase, anticholinergiques, antagonistes du récepteur de NMDA, sympathomimétiques; au moins deux des principes actifs appartenant à des groupes de principes actifs différents.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Medicament preparations for transdermal application... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicament preparations for transdermal application..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament preparations for transdermal application... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2089142

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.